UPF3B and Neurodevelopmental delay: Importantly, in all NDD patients harbouring UPF3B mutations, the upregulation of UPF3A protein levels is correlated with the severity of patients’ disease phenotypes in a reverse way, i.e., less severe disease correlates with higher UPF3A protein levels [117,121].